{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:17:15Z","timestamp":1788599835894,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08785-5","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:22:26Z","timestamp":1768281746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sleep effects in drug-resistant epileptic patients taking perampanel: an observational study"],"prefix":"10.1007","volume":"47","author":[{"given":"Fabio","family":"Lamanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Pardeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tilenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Luppino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Salafica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Barbaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Raineri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8827-7324","authenticated-orcid":false,"given":"Angelo","family":"Labate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"8785_CR1","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109","volume":"52","author":"T Hanada","year":"2011","unstructured":"Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y (2011) Perampanel: a novel, orally active, noncompetitive AMPA- receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52:1331\u20131340. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03109","journal-title":"Epilepsia"},{"key":"8785_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ane.12100","volume":"127","author":"MA Rogawski","year":"2013","unstructured":"Rogawski MA, Hanada T (2013) Preclinical Pharmacology of perampanel, a selective non- competitive AMPA receptor antago- Nist. Acta Neurol Scand Suppl 127:19\u201324. https:\/\/doi.org\/10.1111\/ane.12100","journal-title":"Acta Neurol Scand Suppl"},{"key":"8785_CR3","unstructured":"European Medicines Agency (EMA) Perampanel (Fycompa): Summary of Product Characteristics. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/productinformation\/fycompa-epar-product-information_en.pdf"},{"key":"8785_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/ane.12883","volume":"137","author":"T Nishida","year":"2018","unstructured":"Nishida T, Lee SK, Inoue Y, Saeki K, Ishikawa K, Kaneko S (2018) Adjunctive perampanel in partial-onset seizures: Asia- Pacific, randomized phase III study. Acta Neurol Scand 137:392\u2013399. https:\/\/doi.org\/10.1111\/ane.12883","journal-title":"Acta Neurol Scand"},{"key":"8785_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.122797","volume":"455","author":"A Pascarella","year":"2023","unstructured":"Pascarella A, Gasparini S, Manzo L, Marsico O, Torino C, Abelardo D, Cianci V, Iudice A, Bisulli F, Bonanni P, Caggia E, D\u2019Aniello A, Di Bonaventura C, DiFrancesco JC, Domina E, Dono F, Gambardella A, Marini C, Marrelli A, Matricardi S, Morano A, Paladin F, Renna R, Piccioli M, Striano P, Ascoli M, Ferlazzo E, Aguglia U, PEROC Study Group (2023) Perampanel as only add-on epilepsy treatment in elderly: a subgroup analysis of real-world data from retrospective, multicenter, observational study. J Neurol Sci 455:122797. https:\/\/doi.org\/10.1016\/j.jns.2023.122797","journal-title":"J Neurol Sci"},{"key":"8785_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1182304","volume":"14","author":"F Perversi","year":"2023","unstructured":"Perversi F, Costa C, Labate A, Lattanzi S, Liguori C, Maschio M, Meletti S, Nobili L, Operto FF, Romigi A, Russo E, Di Bonaventura C (2023) The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy. Front Neurol 14:1182304. https:\/\/doi.org\/10.3389\/fneur.2023.1182304","journal-title":"Front Neurol"},{"issue":"11","key":"8785_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","volume":"85","author":"JA French","year":"2015","unstructured":"French JA, Krauss GL, Wechsler RT, Wang XF, DiVentura B, Brandt C, Trinka E, O\u2019Brien TJ, Laurenza A, Patten A, Bibbiani F (2015) Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy a randomized trial. Neurology 85(11):950\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000001930","journal-title":"Neurology"},{"issue":"Suppl 1","key":"8785_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/epi.14456","volume":"60","author":"H Potschka","year":"2019","unstructured":"Potschka H, Trinka E (2019) Perampanel: does it have broad-spectrum potential? Epilepsia 60(Suppl 1):22\u201336. https:\/\/doi.org\/10.1111\/epi.14456","journal-title":"Epilepsia"},{"issue":"16","key":"8785_CR9","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1080\/14656566.2017.1392509","volume":"18","author":"C Di Bonaventura","year":"2017","unstructured":"Di Bonaventura C, Labate A, Maschio M, Meletti S, Russo E (2017) AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives. Expert Opin Pharmacother 18(16):1751\u20131764. https:\/\/doi.org\/10.1080\/14656566.2017.1392509","journal-title":"Expert Opin Pharmacother"},{"key":"8785_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108885","volume":"136","author":"T Yamamoto","year":"2022","unstructured":"Yamamoto T, Gil-Nagel A, Wheless JW, Kim JH, Wechsler RT (2022) Perampanel monotherapy for the treatment of epilepsy: clinical trial and real-world evidence. Epilepsy Behav 136:108885. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108885","journal-title":"Epilepsy Behav"},{"issue":"1","key":"8785_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12883-021-02450-y","volume":"21","author":"P Bonanni","year":"2021","unstructured":"Bonanni P, Gambardella A, Tinuper P, Acone B, Perucca E, Coppola G (2021) Perampanel as first add-on antiseizure medication: Italian consensus clinical practice statements. BMC Neurol 21(1):410. https:\/\/doi.org\/10.1186\/s12883-021-02450-y","journal-title":"BMC Neurol"},{"key":"8785_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106492","volume":"100","author":"S Takahashi","year":"2019","unstructured":"Takahashi S, Shimizu K, Inaji M, Hashimoto S, Yamamoto S, Maehara T (2019) Effectiveness of perampanel as a first add-on antiepileptic drug for the treatment of partial epilepsy. Epilepsy Behav 100:106492. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106492","journal-title":"Epilepsy Behav"},{"issue":"2","key":"8785_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/ane.13197","volume":"141","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim DW, Lee SK, Seo DW, Lee JW, Park HJ, Lee SA (2020) First add-on perampanel for focal-onset seizures: an open- label, prospective study. Acta Neurol Scand 141(2):132\u2013140. https:\/\/doi.org\/10.1111\/ane.13197","journal-title":"Acta Neurol Scand"},{"key":"8785_CR14","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10072-020-04636-7","volume":"42","author":"A Labate","year":"2021","unstructured":"Labate A, Fortunato F, Giugno A et al (2021) Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study. Neurol Sci 42:1389\u20131394. https:\/\/doi.org\/10.1007\/s10072-020-04636-7","journal-title":"Neurol Sci"},{"key":"8785_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2020.100393","volume":"15","author":"A Nilo","year":"2020","unstructured":"Nilo A, Pauletto G, Gigli GL, Vogrig A, Dolso P, Valente M (2020) Perampanel as add-on therapy in epilepsies with known etiology: a single center experience with long-term follow-up. Epilepsy Behav Rep 15:100393. https:\/\/doi.org\/10.1016\/j.ebr.2020.100393","journal-title":"Epilepsy Behav Rep"},{"key":"8785_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116903","volume":"415","author":"A Pascarella","year":"2020","unstructured":"Pascarella A, Iannone LF, Di Gennaro G, D\u2019Aniello A, Ferlazzo E, Gagliostro N, Ursini F, Bonanni P, Paciello N, Romigi A, Aguglia U, De Sarro G, Russo E, Gambardella A, Labate A (2020) The efficacy of perampanel as adjunctive therapy in drugresistant focal epilepsy in a \u201creal world\u201d context: focus on temporal lobe epilepsy. J Neurol Sci 415:116903. https:\/\/doi.org\/10.1016\/j.jns.2020.116903","journal-title":"J Neurol Sci"},{"key":"8785_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.seizure.2020.01.021","volume":"76","author":"R Rocamora","year":"2020","unstructured":"Rocamora R, \u00c1lvarez I, Chavarr\u00eda B, Principe A (2020) Perampanel effect on sleep architecture in patients with epilepsy. Seizure - Eur J Epilepsy 76:137\u2013142. https:\/\/doi.org\/10.1016\/j.seizure.2020.01.021","journal-title":"Seizure - Eur J Epilepsy"},{"key":"8785_CR18","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10072-022-06536-4","volume":"44","author":"M Fernandes","year":"2023","unstructured":"Fernandes M, Lupo C, Spanetta M et al (2023) Sleep\u2013wake cycle and daytime sleepiness in patients with epilepsy after initiating perampanel as adjunctive therapy. Neurol Sci 44:1361\u20131368. https:\/\/doi.org\/10.1007\/s10072-022-06536-4","journal-title":"Neurol Sci"},{"issue":"6","key":"8785_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Mosh\u00e9 SL, Perucca E, Wiebe S, French J (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069\u20131077. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x","journal-title":"Epilepsia"},{"issue":"6","key":"8785_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/epi.15612","volume":"60","author":"A Bernasconi","year":"2019","unstructured":"Bernasconi A, Cendes F, Theodore WH, Gill RS, Koepp MJ, Hogan RE, Jackson GD, Federico P, Labate A, Vaudano AE, Bl\u00fcmcke I, Ryvlin P, Bernasconi N (2019) Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the international league against epilepsy neuroimaging task force. Epilepsia 60(6):1054\u20131068. https:\/\/doi.org\/10.1111\/epi.15612","journal-title":"Epilepsia"},{"key":"8785_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2016.08.004","volume":"63","author":"M Toledo","year":"2016","unstructured":"Toledo M, Gonzalez-Cuevas M, Mir\u00f3-Llad\u00f3 J, Molins-Albanell A, Falip M, Martinez AB, Fernandez S, Quintana M, Cambrodi R, Santamarina E, Salas-Puig J (2016) Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures. Epilepsy Behav 63:57\u201362. https:\/\/doi.org\/10.1016\/j.yebeh.2016.08.004","journal-title":"Epilepsy Behav"},{"key":"8785_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.eplepsyres.2016.08.001","volume":"126","author":"V Villanueva","year":"2016","unstructured":"Villanueva V, Garc\u00e9s M, L\u00f3pez-Gonz\u00c1lez FJ, Rodriguez-Osorio X, Toledo M, SalasPuig J et al (2016) Safety, efficacy and outcome-related factors of perampanel over 12 months in a real- world setting: the FYDATA study. Epilepsy Res 126:201\u2013210. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.001","journal-title":"Epilepsy Res"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08785-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:02:49Z","timestamp":1773072169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08785-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8785"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08785-5","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Publication Statement"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"154"}}